Copyright Reports & Markets. All rights reserved.

Global Meningococcal Group B Vaccine Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Meningococcal Group B Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Meningococcal Group B Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Type
    • 1.4.2 Type 1
    • 1.4.3 Type 2
  • 1.5 Market by Application
    • 1.5.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Application
    • 1.5.2 Public
    • 1.5.3 Private
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Meningococcal Group B Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Meningococcal Group B Vaccine Revenue 2015-2026
    • 2.1.2 Global Meningococcal Group B Vaccine Sales 2015-2026
  • 2.2 Global Meningococcal Group B Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Meningococcal Group B Vaccine Competitor Landscape by Players

  • 3.1 Meningococcal Group B Vaccine Sales by Manufacturers
    • 3.1.1 Meningococcal Group B Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Meningococcal Group B Vaccine Revenue by Manufacturers
    • 3.2.1 Meningococcal Group B Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Meningococcal Group B Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Meningococcal Group B Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Meningococcal Group B Vaccine Revenue in 2019
    • 3.2.5 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Meningococcal Group B Vaccine Price by Manufacturers
  • 3.4 Meningococcal Group B Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Meningococcal Group B Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Meningococcal Group B Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Meningococcal Group B Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Meningococcal Group B Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Meningococcal Group B Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Meningococcal Group B Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Meningococcal Group B Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Meningococcal Group B Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Meningococcal Group B Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Meningococcal Group B Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Meningococcal Group B Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Meningococcal Group B Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Meningococcal Group B Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Meningococcal Group B Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Meningococcal Group B Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Meningococcal Group B Vaccine Price by Application (2015-2020)
  • 5.2 Meningococcal Group B Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Meningococcal Group B Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Meningococcal Group B Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Meningococcal Group B Vaccine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Meningococcal Group B Vaccine by Country
    • 6.1.1 North America Meningococcal Group B Vaccine Sales by Country
    • 6.1.2 North America Meningococcal Group B Vaccine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Meningococcal Group B Vaccine Market Facts & Figures by Type
  • 6.3 North America Meningococcal Group B Vaccine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Meningococcal Group B Vaccine by Country
    • 7.1.1 Europe Meningococcal Group B Vaccine Sales by Country
    • 7.1.2 Europe Meningococcal Group B Vaccine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Meningococcal Group B Vaccine Market Facts & Figures by Type
  • 7.3 Europe Meningococcal Group B Vaccine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Meningococcal Group B Vaccine by Region
    • 8.1.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region
    • 8.1.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Type
  • 8.3 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Meningococcal Group B Vaccine by Country
    • 9.1.1 Latin America Meningococcal Group B Vaccine Sales by Country
    • 9.1.2 Latin America Meningococcal Group B Vaccine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Meningococcal Group B Vaccine Market Facts & Figures by Type
  • 9.3 Central & South America Meningococcal Group B Vaccine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Meningococcal Group B Vaccine by Country
    • 10.1.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country
    • 10.1.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description and Business Overview
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Meningococcal Group B Vaccine Products Offered
    • 11.1.5 GSK Related Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description and Business Overview
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Meningococcal Group B Vaccine Products Offered
    • 11.2.5 Pfizer Related Developments
  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description and Business Overview
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Meningococcal Group B Vaccine Products Offered
    • 11.1.5 GSK Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Meningococcal Group B Vaccine Market Estimates and Projections by Region
    • 12.1.1 Global Meningococcal Group B Vaccine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Meningococcal Group B Vaccine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Meningococcal Group B Vaccine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Meningococcal Group B Vaccine Sales Forecast (2021-2026)
    • 12.2.2 North America: Meningococcal Group B Vaccine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Meningococcal Group B Vaccine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Meningococcal Group B Vaccine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Meningococcal Group B Vaccine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Meningococcal Group B Vaccine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Meningococcal Group B Vaccine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Meningococcal Group B Vaccine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Meningococcal Group B Vaccine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Meningococcal Group B Vaccine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Meningococcal Group B Vaccine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Meningococcal Group B Vaccine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Meningococcal Group B Vaccine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Meningococcal Group B Vaccine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Meningococcal Group B Vaccine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Meningococcal Group B Vaccine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Meningococcal Group B Vaccine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Meningococcal Group B Vaccine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Meningococcal Group B Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Meningococcal Group B Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Meningococcal Group B Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Meningococcal Group B Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Group B Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Meningococcal Group B Vaccine market is segmented into
    Type 1
    Type 2

    Segment by Application, the Meningococcal Group B Vaccine market is segmented into
    Public
    Private

    Regional and Country-level Analysis
    The Meningococcal Group B Vaccine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Meningococcal Group B Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Meningococcal Group B Vaccine Market Share Analysis
    Meningococcal Group B Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meningococcal Group B Vaccine business, the date to enter into the Meningococcal Group B Vaccine market, Meningococcal Group B Vaccine product introduction, recent developments, etc.

    The major vendors covered:
    GSK
    Pfizer
    ...

    Buy now